on MDBriefCase
MDBriefCase Announces Relaunch of RxBriefCase for Pharmacists
TORONTO, ON / ACCESSWIRE / September 25, 2024 / MDBriefCase will relaunch RxBriefCase, a leading continuing education platform for pharmacists, in partnership with Pharmapod. Set to launch in early 2025, RxBriefCase will offer on-demand accredited pharmacy courses to keep pharmacists' skills current.
The courses will cover patient safety, travel medicine, medication management, and infectious disease. This relaunch emphasizes MDBriefCase's commitment to clinical education.
Sachin Aggarwal, CEO of Think Research, stated, "Our goal is to empower pharmacists with the tools and knowledge they need for exceptional patient care."
Janet Kimura, Managing Director & EVP at MDBriefCase, expressed excitement about bringing back RxBriefCase with enhanced content. Brynne Eaton-Auva'a, Managing Director, Clinical Connectivity, emphasized the collaboration with Pharmapod to make education and safety accessible.
Pharmacists can anticipate an engaging platform that fits into their schedules, accessible directly via Pharmapod.
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all MDBriefCase news